Anaptysbio Stock Investor Sentiment
| ANAB Stock | USD 24.10 1.83 8.22% |
About 59% of AnaptysBio's investor base is looking to short. The analysis of the overall investor sentiment regarding AnaptysBio suggests that many traders are alarmed. The current market sentiment, together with AnaptysBio's historical and current headlines, can help investors time the market. In addition, many technical investors use AnaptysBio stock news signals to limit their universe of possible portfolio assets.
AnaptysBio |
AnaptysBio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards AnaptysBio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about AnaptysBio that are available to investors today. That information is available publicly through AnaptysBio media outlets and privately through word of mouth or via AnaptysBio internal channels. However, regardless of the origin, that massive amount of AnaptysBio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AnaptysBio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AnaptysBio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AnaptysBio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AnaptysBio alpha.
AnaptysBio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 1300 shares by Orwin John A of AnaptysBio subject to Rule 16b-3 | 09/13/2024 |
2 | Disposition of 10000 shares by Dennis Mulroy of AnaptysBio at 40.13 subject to Rule 16b-3 | 09/16/2024 |
3 | Disposition of 3780 shares by Eric Loumeau of AnaptysBio at 38.4103 subject to Rule 16b-3 | 09/17/2024 |
4 | TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Singular Genomics Systems Inc | 09/18/2024 |
5 | Disposition of 5000 shares by Eric Loumeau of AnaptysBio at 14.02 subject to Rule 16b-3 | 10/14/2024 |
6 | AMD, Eli Lilly slide Google, Visa rise among Wednesdays afternoon market cap stock movers | 10/30/2024 |
7 | HC Wainwright Reaffirms Buy Rating for AnaptysBio | 10/31/2024 |
8 | AnaptysBio GAAP EPS of -1.14 beats by 0.51, revenue of 30.02M beats by 21.85M | 11/05/2024 |
9 | Revenue Rises to 30M in AnaptysBio Inc. Q3 2024, EPS of -1.14 Exceeds Estimates | 11/06/2024 |
10 | AnaptysBio, Inc. May Have Run Too Fast Too Soon With Recent 33 percent Price Plummet | 11/07/2024 |
11 | AnaptysBio Upgraded to Buy What Does It Mean for the Stock | 11/08/2024 |
12 | Disposition of 2000 shares by Lizzul Paul F. of AnaptysBio at 40.0 subject to Rule 16b-3 | 11/22/2024 |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |